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Objective: The primary purpose of this study was to confirm
the association of a specific haplotype of the dopamine trans-
porter gene and attention deficit hyperactivity disorder
(ADHD), which could be one source of the heterogeneity seen
across published studies.
Method: The authors previously reported the association of
ADHD with a subgroup of chromosomes containing specific al-
leles of two variable-number tandem repeat polymorphisms
within the 3′ untranslated region and intron 8 of the dopa-
mine transporter gene. They now report on this association in
a sample of ADHD combined-type probands.
Results: The original observations were confirmed, with an
overall odds ratio of 1.4 across samples.
Conclusions: These data challenge results of meta-analyses
suggesting that dopamine transporter variation does not have
an effect on the risk for ADHD, and they indicate that further
investigation of functional variation in the gene is required.
(Am J Psychiatry 2007; 164:674–677)
Attention deficit hyperactivity disorder (ADHD) is one
of the most prevalent and heritable behavioral disorders of
childhood. The disorder is characterized by onset of age-in-
appropriate hyperactivity, impulsivity, and inattentiveness
before the age of 7 years. A familial risk has been established,
and twin studies demonstrate the important role of genetic
factors, with heritability estimates in the range of 60%–90%.
Efforts to identify genes associated with ADHD have been
relatively fruitful by focusing on genes that regulate dopam-
ine and related monoamine neurotransmitter systems (1).
One of the most prominent findings in ADHD research
has been the association between the 10-repeat allele of a
40-base-pair variable-number tandem repeat (VNTR) in
the 3′-untranslated (3′UTR) region of the dopamine trans-
porter gene (DAT1). Although the association has been re-
ported in multiple studies since the initial report by Cook
et al. in 1995 (2), there have also been many nonreplica-
tions (see references 1, 3, and 4 for reviews). Meta-analyses
of available data have found the net effect across studies to
be very small (3), and one recent study suggested no effect
at all (5). However, several authors have also noted that the
DAT1 data show significant evidence of heterogeneity
across Caucasian data sets (5–7). The reason for this heter-
ogeneity is not well understood.
One possible contribution to heterogeneity between
data sets might occur if the 10-repeat allele was tagging a
nearby functional variant in partial linkage disequilib-
rium (LD) with the 10-repeat allele, with different levels of
LD occurring in different populations. Alternatively, the
10-repeat allele may confer risk for ADHD only in combi-
nation with additional DNA variants in the DAT1 gene,
and the specific combination might occur at different fre-
quencies in various populations. Data supporting the role
of alternative functional sites within DAT1 came from the
recent study (8) of two distinct ADHD samples from the
United Kingdom and Taiwan in which the association
with ADHD was specific to a particular haplotype. The
risk haplotype identified in the study consisted of the 10-
repeat allele in the 3′UTR in conjunction with the six-re-
peat allele (which in our previous report we referred to as
the three-repeat allele) of a 30-base pair VNTR located
within intron 8 (8). Since we know now that the repeat
units are three more than originally reported, we have al-
tered the allele numbering system to reflect this change;
for example, the five-repeat allele was previously reported
as a two-repeat allele and the six-repeat allele as a three-
repeat allele. Of the four possible common haplotype
combinations of the two markers (9-5, 9-6, 10-5, 10-6),
This article is featured in this month’s AJP Audio.
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only the 10-6 haplotype was associated with increased
risk for ADHD in both populations.
Since then we have further investigated this key finding
in a large sample of combined-subtype ADHD probands
collected for the International Multicenter ADHD Gene
(IMAGE) project.
Method
Descriptions of the clinical sample and the genotype assays
are reported in detail elsewhere (9). In brief, the sample consists
of European Caucasian subjects recruited from 11 specialist clin-
ics in eight countries: Belgium, Germany, Holland, Ireland, Is-
rael, Spain, Switzerland, and the United Kingdom. All ADHD
probands and their siblings were 5 to 17 years of age at the time
of entry into the study, and access to one or both biological par-
ents was required. Entry criteria for probands were a clinical di-
agnosis of DSM-IV combined-subtype ADHD and having one or
more full siblings available for ascertainment of clinical informa-
tion and DNA collection. Exclusion criteria applying to both
probands and siblings included autism, epilepsy, IQ <70, brain
disorders, and any genetic or medical disorder associated with
externalizing behaviors that might mimic ADHD. A standardized
algorithm was applied to data from the Parent Account of Child-
hood Symptoms, a semistructured investigator-based interview
developed to provide objective measures of child behavior (10),
to derive each of the 18 DSM-IV ADHD items. These are com-
bined with items that scored 2 or 3 from the ADHD subscale of
the Conners’s Teacher Rating Scale (11) to generate the total
number of items from the DSM-IV symptom checklist. Situa-
tional pervasiveness was defined as some symptoms occurring
in two or more different situations from the Parent Account of
Childhood Symptoms interview or the presence of one or more
symptoms scoring 2 or more from the ADHD subscale of the
Conners Teacher Rating Scale.
The final sample used in this study consisted of 998 families
containing a total of 1,159 DSM-IV combined-type ADHD
probands. DNA from both parents was available for 82.6% of
probands (N=957) and from one parent for 13.8% (N=160). Most
of the probands (86.6%, N=998) were male; 53.4% (N=620) had
comorbid oppositional defiant disorder, and 24.3% (N=282) had
conduct disorder; and 72.9% (N=845) were receiving medication
for ADHD at the time of the research evaluations. Our analysis
was conducted with the transmission disequilibrium test imple-
mented in the software application UNPHASED (http://
www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/).
Genotype frequencies are available from the authors.
Results
We have already reported results from the first set of 776
probands from this sample (9), in which we found that,
similar to the initial U.K. and Taiwanese samples, only the
10-6 haplotype was overtransmitted from heterozygote
parents to affected offspring (haplotype-specific p<0.06,
odds ratio=1.19). We now find a similar pattern of findings
in the second set of 383 ADHD probands from the IMAGE
sample (haplotype-specific p<0.002, odds ratio=1.52). The
evidence for the haplotype association in the IMAGE
dataset is therefore very strong (Table 1). Overall we find
global evidence for association with the 3′UTR VNTR (p=
0.019), the intron 8 VNTR (p=0.013), and the haplotype of
the two markers (p=0.020). Examination of the allele-spe-
cific associations shows that for the individual markers, it
TABLE 1. Transmission Disequilibrium Test Association Results for the International Multicenter ADHD Gene Project Sam-
ple, Using 1,159 Triosa
Polymorphism and Allele Transmitted Allelesb Non-transmitted Allelesb p Odds Ratio
3′UTR (p=0.0186)
6 1 2 — —
7 1 0 — —
8 3 0 — —
9 333 409 0.005 0.81
10 418 347 0.010 0.21
11 35 33 — —
Intron 8 (p=0.0132)
4 1 1 — —
5 286 354 0.007 0.81
6 354 298 0.03 1.19
7 0 1 — —
9 24 11 0.03 2.2
Haplotype (p=0.0197)
6-5 1 2 — —
8-6 3 0 — —
9-4 1 1 — —
9-5 180 213 0.10 0.85
9-6 124 163 0.02 0.76
10-5 84 99 0.27 0.85
10-6 381 301 0.002 1.27
10-7 0 1 — —
10-9 16 10 0.24 1.6
11-5 1 2 — —
11-6 23 28 0.48 0.82
11-9 7 1 — —
a Significant association of the two markers was observed, with allele-specific overtransmission of the 10- and six-repeat alleles both individu-
ally and when combined in a haplotype. Note that the annotation of the repeat alleles for the intron 8 variable-number tandem repeat
marker has changed since our previous reports (8, 9); the previous 1-repeat has been revised as 4-repeat, 2-repeat as 5-repeat, 3-repeat as 6-
repeat, 4-repeat as 7-repeat, and 6-repeat as 9-repeat.
b From heterozygote parents.
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is the 10-repeat and six-repeat alleles that are associated
with risk for ADHD. More specifically, only the 10-6 com-
bination is overtransmitted to ADHD offspring, whereas
all other haplotype combinations are undertransmitted
(haplotype-specific p=0.002, odds ratio=1.27), confirming
the previous observation of a haplotype-specific associa-
tion. The only possible exception is the observation in this
sample that the rare nine-repeat allele from the intron 8
VNTR might also be overtransmitted to affected offspring.
Discussion
We are not aware of other available ADHD datasets that
have genotyped the intron 8 VNTR together with the
3′UTR VNTR. The overall evidence to date combining the
IMAGE data with the previously published data (8) for the
10-6 haplotype association shows 484 transmissions ver-
sus 341 nontransmissions (global p=4.26×10–5, haplotype-
specific p=6×10–7, odds ratio=1.4), with none of the other
three common haplotypes showing overtransmission to
affected offspring.
Although in the combined data set we found associa-
tions of ADHD to both the 3′UTR VNTR (p=0.0005) and the
intron 8 VNTR (p=0.0002), the important observation is
that of the four possible common haplotype combina-
tions, only the 10-6 haplotype is overtransmitted to af-
fected offspring. This indicates that neither the 10-repeat
allele nor the six-repeat allele alone can explain the associ-
ation. To formally test this hypothesis, an alternative
transmission disequilibrium test program, Whap (avail-
able at http://pngu.mgh.harvard.edu/~purcell/whap/),
was used to investigate the effect of one marker condi-
tional on the other. We compared the null hypothesis that
the 10-6 haplotype is associated with ADHD and the alter-
native hypotheses of association with either the 10-repeat
or the six-repeat allele alone. Dropping either VNTR from
the analysis led to a significant drop in significance of the
haplotype association (3′UTR p=0.002, intron 8 p=0.005),
indicating that both markers contribute significantly to
the haplotype association. Several other groups have iden-
tified haplotype-specific associations with the 10-repeat
allele in combination with another allele from a second
marker (12–14), so the finding of haplotype-specific asso-
ciations in this region is not unique to this study.
There are two main interpretations of these data. First,
the two markers tag an as-yet unidentified causal variant
that is in partial LD with the two markers. Second, there is
a direct interaction between the two VNTR markers (or
other causal variants in strong LD with the VNTR markers).
LD is a measure of the correlation between marker geno-
types on the same chromosome and can be very high for
markers with similar allele frequencies that lie close to-
gether. In the IMAGE sample, we found that LD between
the two markers was moderate to low (D′=0.42, R2=0.25)
and was similar to that seen in the U.K. and Taiwanese
samples (8). The partial LD explains why the haplotype is
more informative than the 3′UTR marker alone, since only
a subset of chromosomes with the 10-repeat allele are as-
sociated with ADHD, whereas if LD were 0.8 or above, we
would expect the intron 8 and 3′UTR markers to merely tag
each other. Since the marker genotypes are correlated to a
moderate degree, we cannot distinguish between the
marker haplotype tagging a nearby functional variant and
a two-locus interaction.
Taken together, these data challenge the results of meta-
analyses that suggest no effect of DAT1 variation on risk for
ADHD and indicate that further investigation of functional
variation across the gene is required. In the most recent
meta-analysis, Li et al. (6) concluded that a negative result is
conclusive only if the entire gene has been tagged and there
is sufficient power and uniformity in the studies. Other
sources of heterogeneity, such as phenotypic differences
between samples and interactions with environmental
variables, may also be important but have yet to be system-
atically investigated.
Received June 20, 2006; revision received Aug. 4, 2006; accepted
Aug. 29, 2006. From the MRC Social Genetic Developmental and Psy-
chiatry Centre, Institute of Psychiatry, London; University Clinic for
Child and Adolescent Psychiatry, Essen, Germany; Geha Mental
Health Center, Petach-Tikva, Israel; Department of Child and Adoles-
cent Psychiatry, University of Göttingen, Göttingen, Germany; Depart-
ment of Psychiatry, Radboud University Nijmegen Medical Center,
Nijmegen, the Netherlands; Department of Developmental and Edu-
cational Psychology, University of Valencia, Valencia, Spain; School of
Psychology, University of Southampton, Highfield, Southampton,
U.K.; Vrije Universiteit, Amsterdam; ADHD Clinic, Geha Mental Health
Center, Petak Tikvah, Israel; S. Herzog Memorial Hospital, Jerusalem;
Department of Psychiatry, Trinity Centre for Health Sciences, St.
James’s Hospital, Dublin; Ghent University, Ghent, Belgium; Depart-
ment of Child and Adolescent Psychiatry, University of Zurich, Zurich,
Switzerland; and Child and Adolescent Psychiatry Research, SUNY
Upstate Medical University, Syracuse, N.Y. Address correspondence
and reprint requests to Prof. Asherson, MRC Social Genetic Develop-
mental and Psychiatry Centre, Institute of Psychiatry, London, SE5
8AF UK; p.asherson@iop.kcl.ac.uk (e-mail).
Dr. Banaschewski has served as adviser or consultant to Lilly, Med-
ice, Shire, and UCB and has received speakers honoraria or confer-
ence attendance support from Janssen/McNeil, Lilly, Medice, and
UCB. Dr. Faraone has received grants from, acted as a consultant to,
and been on the speakers bureau of Eli Lilly and Company, McNeil
Consumer and Specialty Pharmaceuticals, and Shire U.S. He has also
acted as a consultant to Noven Pharmaceuticals and Cephalon and
has been on the speakers bureau of Cephalon and Novartis. All other
authors report no competing interests.
The IMAGE project is a multisite international effort supported by
NIH grant R01MH62873 to Dr. Faraone. Site principal investigators
are Philip Asherson, Tobias Banaschewski, Jan Buitelaar, Richard P.
Ebstein, Stephen V. Faraone, Michael Gill, Ana Miranda, Robert D.
Oades, Herbert Roeyers, Aribert Rothenberger, Joseph Sergeant, Ed-
mund Sonuga-Barke, and Hans-Christoph Steinhausen. Senior co-in-
vestigators are Margaret Thompson, Pak Sham, Peter McGuffin, Rob-
ert Plomin, Ian Craig, and Eric Taylor. Chief investigators at each site
are Rafaela Marco, Nanda Rommelse, Fernando Mulas, Wai Chen,
Henrik Uebel, Hanna Christiansen, U. Mueller, Cathelijne Buschgens,
Barbara Franke, and Lamprini Psychogiou. Other investigators are
Marieke Altink, Ellen Fliers, Ruud Minderaa, and Alysa Doyle.
Am J Psychiatry 164:4, April 2007 677
BRIEF REPORTS
ajp.psychiatryonline.org
References
1. Asherson P, IMAGE Consortium: Attention deficit hyperactivity
disorder in the post-genomic era. Eur J Child Adoles Psych
2004; 13(suppl 1):I50–I70
2. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE,
Leventhal BL: Association of attention deficit disorder and the
dopamine transporter gene. Am J Hum Genet 1995; 56:993–
998
3. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ,
Holmgren MA, Sklar P: Molecular genetics of attention-deficit/
hyperactivity disorder. Biol Psychiatry 2005; 57:1313–1323
4. Thapar A, O’Donovan M, Owen MJ: The genetics of attention
deficit hyperactivity disorder. Hum Mol Genet 2005; 14(spec no
2):275–282
5. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L,
Sharp J, Batten C, Fernando S, Ozbay F, Yazgan Y, Simonoff E,
Thompson M, Taylor E, Asherson P: Association study of a
dopamine transporter polymorphism and attention deficit hy-
peractivity disorder in UK and Turkish samples. Mol Psychiatry
2001; 6:425–428
6. Li D, Sham PC, Owen MJ, He L: Meta-analysis shows significant
association between dopamine system genes and attention
deficit hyperactivity disorder. Hum Mol Genet 2006; 15:2276–
2284
7. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM: Dopamine
system genes and attention deficit hyperactivity disorder: a
meta-analysis. Psychiatr Genet 2002; 12:207–215
8. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J, Chen
CK, Huang YS, Sethna V, Taylor E, Chen W, Breen G, Asherson P:
A common haplotype of the dopamine transporter gene asso-
ciated with attention-deficit/hyperactivity disorder and inter-
acting with maternal use of alcohol during pregnancy. Arch
Gen Psychiatry 2006; 63:74–81
9. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Aneley R,
Franke B, Gill M, Ebstein R, Buitelaar J, Sham PC, Cambell D,
Knight J, Andreou P, Altink M, Arnold R, Boer F, Buschgens C,
Butler L, Christiansen H, Feldman L, Fleischman K, Fliers E,
Howe-Forbes R, Goldfarb A, Heise A, Gabriëls I, Lubetzki I,
Marco R, Medad S, Minderaa R, Mulas F, Müller U, Mulligan A,
Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psycho-
giou L, Weeks A, Barrett R, Craig I, Banaschewski T, Sonuga-
Barke E, Eisenberg J, Kuntsi J, Manor I, McGuffin P, Miranda A,
Oades RD, Plomin R, Roeyers H, Rothenberger A, Sergeant J,
Steinhausen H-C, Taylor E, Thompson M, Faraone SV, Asherson
P: The analysis of 51 genes in DSM-IV combined type attention
deficit hyperactivity disorder: association signals in DRD4,
DAT1, and 16 other genes. Mol Psychiatry 2006; 11:934–953
10. Taylor E, Schachar R, Thorley G, Wieselberg M: Conduct disor-
der and hyperactivity, I: separation of hyperactivity and antiso-
cial conduct in British child psychiatric patients. Br J Psychiatry
1986; 149:760–767
11. Werry JS, Sprague RL, Cohen MN: Conners’ Teacher Rating Scale
for use in drug studies with children: an empirical study. J Ab-
norm Child Psychol 1975; 3:217–229
12. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Scha-
char R, Malone M, Roberts W, Nothen MM, Grunhage F, Van-
denbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL: Haplo-
type study of three polymorphisms at the dopamine
transporter locus confirms linkage to attention/deficit-hyperac-
tivity disorder. Biol Psychiary 2001; 49:333–339
13. Galili-Weisstub E, Levy S, Frisch A, Gross-Tsur V, Michaelovsky E,
Kosov A, Meltzer A, Goltser T, Serretti A, Cusin C, Darvasi A, In-
bar E, Weizman A, Segman RH: Dopamine transporter haplo-
type and attention deficit hyperactivity disorder. Mol Psychia-
try 2005; 10:617–618
14. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood
T, Kelsoe J, Fitzgerald M, Gill M: Linkage disequilibrium map-
ping at DAT1, DRD5, and DBH narrows the search for ADHD
susceptibility alleles at these loci. Mol Psychiarty 2003; 8:299–
308
